To assess the impact of Trim21 on breast cancer cell function, we first analyzed several publicly available datasets, and revealed that elevated Trim21 expression was associated with better OS, RFS, and DMFS in breast cancer patients (Supplementary Fig. 6A–C). Here, TRIM21 is linked to breast carcinoma.